[1] Akman B, Tarhan C, Arat Z, et al. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients [J]. Ren Fail, 2009, 31(3): 196-200.
[2] Abchee A, El-Sibai M, Youhanna S, et al. The I allele of the angiotensin converting enzyme I/D polymorphism confers protection against coronary artery disease [J]. Coron Artery Dis, 2010, 21(3): 151- 156.
[3] Cui J H, Yang G, Su X K, et al. Study on gene polymorphism of AGT, ACE and MTHFR in cerebral infarction patients [J]. Journal of Clincal Research, 2008, 25(10): 1752-1754 (in Chinese). 崔金环,杨 光,苏锡康,等. 脑梗死患者AGT、ACE和MTHFR基因多态性的研究 [J]. 医学临床研究,2008, 25(10): 1752-1754.
[4] Tascilar N, Dursun A, Ankarali H. Angiotensin-converting enzyme insertion/deletion polymorphism has no effect on the risk of atherosclerotic stroke or hypertension [J]. J Neurol Sci, 2009, 285(1/2): 137-141.
[5] Coto-Segura P, Alvarez V, Soto-Sánchez J, et al. Lack of association between angiotensin I-converting enzyme insertion/deletion polymorphism and psoriasis or psoriatic arthritis in Spain [J]. Int J Dermatol, 2009, 48(12):1320-1323.
[6] Mo Y P, Zhang Y, Zhang H X, et al. Correlation between a polymorphism of the angiotensin-converting enzyme and essential hypertension in Yi People of Yunnan Province [J]. Academic Journal of Kunming Medical College, 2009, 30(9): 67-72 (in Chinese). 莫艳萍,张 彦,张红星,等. ACE基因多态性与云南彝族原发性高血压的相关性研究 [J].昆明医学院学报,2009, 30(9): 67-72.
[7] Ferrario C M. Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research [J]. J Renin Angiotensin Aldosterone Syst, 2006, 7(1): 3-14.
[8] Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels [J]. Am J Hum Genet, 1992, 51(1): 197-205.
[9] Suehiro T, Morita T, Inoue M, et al. Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion [J]. Hum Genet, 2004, 115(2):91-96.
[10] An P, Zhao X C, Wang Y Q, et al. Effects of bradykinin preconditioning on cerebral ischemia [J]. Chinese Pharmacological Bulletin, 2006, 22(1): 27-30 (in Chinese). 安 平,赵晓春,王玉勤,等. 缓激肽预处理对大鼠局灶性脑缺血的影响 [J]. 中国药理学通报,2006, 22(1): 27-30.
[11] Penesova A, Cizmarova E, Kvetnansky R, et al. Insertion/deletion polymorphism on ACE gene is associated with endothelial dysfunction in young patients with hypertension [J]. Horm Metab Res, 2006, 38(9): 592-597.
[12] Du M Y, Du H S, Zhou J, et al. Relationship of angiotensinogen gene CD235Met-Thr variant and hypertension disease complicated with cerebral infarction [J]. Journal of the Graduate School of the Chinese Academy of Sciences, 2010, 27(1): 133-137 (in Chinese). 杜明艳,杜会山,周 桔,等. 血管紧张素原基因CD235Met-Thr变异与高血压脑梗塞发病的相关性 [J]. 中国科学院研究生院学报, 2010. 27(1): 133-137.
|